Transocean
RIG NYSE Oil & Gas Drilling Financials FY2016–FY2025
Transocean's revenue rose 12.5% to $4.0 billion in fiscal 2025. Its operating margin was −58.9%, down from −11.8% a year earlier. Free cash flow was $626 million, up 224.3%. The diluted share count rose 3.8%.
About these figures. Transocean's short-term investments matured in 2018 and its balance sheets show none after that, so they count as zero. Transocean's 2025 operating loss made its EBITDA negative, so net debt to EBITDA is blank for that year.
What Transocean does
No business description yet.
- Legal name
- Transocean Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- —
- Accession · CIK
- 0001451505-26-000018
0001451505
Revenue and margins
Transocean had $4.0B of revenue in fiscal 2025, up 12.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $626M in fiscal 2025, 15.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Transocean returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 3.8%.
Value Transocean yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$5.0B and divides by 960.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably Transocean can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $976M | $683M | $762M | $560M | $620M |
| Debt incl. finance leases | $7.2B | $7.3B | $7.4B | $6.9B | $5.7B |
| Net debt / EBITDA | 9.8x | 9.5x | 15.9x | 19.6x | — |
| Debt / equity | 0.6x | 0.7x | 0.7x | 0.7x | 0.7x |
| Interest coverage | −0.3x | −0.1x | −0.5x | −1.2x | −4.2x |
| Current ratio | 1.9x | 1.3x | 1.5x | 1.5x | 1.6x |
| Quick ratio | 1.9x | 1.3x | 1.5x | 1.5x | 1.6x |
| Total assets | $20.7B | $20.4B | $20.3B | $19.4B | $15.6B |
| Total liabilities | $9.5B | $9.6B | $9.8B | $9.1B | $7.5B |
| Shareholders' equity | $11.2B | $10.8B | $10.4B | $10.3B | $8.1B |
| Net debt (− = net cash) | $6.2B | $6.7B | $6.7B | $6.3B | $5.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.2M
1 insider
Sold, 12 months
$4.8M
5 insiders
Of sales under plans
27%
$1.3M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Chad C DeatonDirector | Bought | 35,000 | $4.95 | $0.2M | Form 4 |
| May 21, 2026 | Brady K LongEVP & Chief Legal Officer | Sold | 81,741 | $7.45 | $0.6M | Form 4 |
| Mar 4, 2026 | Roderick James MackenzieEVP, Chief Commercial Officer | Sold | 78,370 | $6.36 | $0.5M | Form 4 |
| Jan 27, 2026 | Brady K LongEVP & Chief Legal Officer | Sold plan | 99,293 | $5.00 | $0.5M | Form 4 |
| Jan 27, 2026 | Keelan AdamsonPresident and CEO, Director | Sold plan | 58,687 | $5.00 | $0.3M | Form 4 |
| Jan 26, 2026 | Brady K LongEVP & Chief Legal Officer | Sold plan | 16,085 | $5.00 | $0.1M | Form 4 |
| Jan 26, 2026 | Keelan AdamsonPresident and CEO, Director | Sold plan | 22,846 | $5.00 | $0.1M | Form 4 |
| Dec 5, 2025 | Keelan AdamsonPresident and CEO, Director | Sold plan | 57,968 | $4.50 | $0.3M | Form 4 |
| Dec 4, 2025 | Keelan AdamsonPresident and CEO, Director | Sold plan | 8,469 | $4.50 | $0.0M | Form 4 |
| Dec 3, 2025 | Roderick James MackenzieEVP, Chief Commercial Officer | Sold | 35,000 | $4.48 | $0.2M | Form 4 |
| Nov 26, 2025 | Jeremy D ThigpenExecutive Chair, Director | Sold | 500,000 | $4.32 | $2.2M | Form 4 |
| Nov 26, 2025 | Robert Thaddeus VaydaEVP, Chief Financial Officer | Sold | 30,000 | $4.29 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✕ | ✓ | ✓ |
| Current ratio rose | ✓ | ✕ | ✓ |
| Share count didn't rise | ✕ | ✕ | ✕ |
| Gross margin rose | ✕ | ✓ | ✓ |
| Revenue rose relative to assets | ✓ | ✓ | ✓ |
| F-score | 4 / 9 | 6 / 9 | 6 / 9 |
| Accruals ratio | −5.5% | −4.8% | −20.9% |
| Altman Z'' | 0.59 | 0.55 | −1.12 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Transocean RIG | $7.7B | 12.5% | −58.9% | 15.8% | −12.4% | — | 6 | |
| Helmerich & Payne HP | $3.9B | 35.9% | 0.1% | 3.1% | 0.1% | — | 4 | Compare → |
| Noble NE | $7.6B | 7.5% | 12.7% | 13.2% | 5.3% | 50.7x | 5 | Compare → |
| Patterson-UTI Energy PTEN | $4.6B | −10.3% | −0.9% | 7.7% | −0.8% | — | 6 | Compare → |
| Valaris VAL | $6.9B | 0.3% | 20.1% | 8.6% | 14.4% | 7.3x | 7 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.2B | $3.0B | $3.0B | $3.1B | $3.2B | $2.6B | $2.6B | $2.8B | $3.5B | $4.0B |
| Gross profit | $2.3B | $1.6B | $1.2B | $948M | $1.2B | $859M | $896M | $846M | $1.3B | $1.6B |
| Operating income | $1.1B | −$2.5B | −$1.3B | −$721M | −$493M | −$112M | −$31.0M | −$325M | −$417M | −$2.3B |
| Interest expense | $409M | $491M | $620M | $660M | $575M | $447M | $561M | $646M | $362M | $555M |
| Pretax income | $934M | −$3.0B | −$1.8B | −$1.2B | −$541M | −$470M | −$562M | −$941M | −$523M | −$2.9B |
| Income tax | $107M | $94.0M | $228M | $59.0M | $27.0M | $121M | $59.0M | $13.0M | −$11.0M | −$33.0M |
| Net income | $778M | −$3.1B | −$2.0B | −$1.3B | −$567M | −$592M | −$621M | −$954M | −$512M | −$2.9B |
| Diluted EPS | $2.08 | −$8.00 | −$4.27 | −$2.05 | −$0.92 | −$0.93 | −$0.89 | −$1.24 | −$0.76 | −$3.04 |
| Diluted shares | 0.37B | 0.39B | 0.47B | 0.61B | 0.62B | 0.64B | 0.70B | 0.77B | 0.93B | 0.96B |
| Cash flow | ||||||||||
| Cash from operations | $2.0B | $1.2B | $558M | $340M | $398M | $575M | $448M | $164M | $447M | $749M |
| Capital expenditure | $1.3B | $497M | $184M | $387M | $265M | $208M | $717M | $427M | $254M | $123M |
| Free cash flow | $636M | $673M | $374M | −$47.0M | $133M | $367M | −$269M | −$263M | $193M | $626M |
| Depreciation and amortization | $893M | $832M | $818M | $855M | $781M | $742M | $735M | $744M | $739M | $659M |
| Stock-based compensation | $42.0M | $41.0M | $45.0M | $37.0M | $31.0M | $28.0M | $29.0M | $40.0M | $47.0M | $35.0M |
| Acquisitions | $0.0M | $0.0M | $883M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $3.1B | $3.0B | $2.2B | $1.8B | $1.2B | $976M | $683M | $762M | $560M | $620M |
| Total debt | $8.5B | $7.4B | $10.0B | $9.3B | $7.8B | $7.2B | $7.3B | $7.4B | $6.9B | $5.7B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $479M | $444M | $406M | $363M | $319M | $271M | $220M |
| Current assets | $5.1B | $4.6B | $3.9B | $3.6B | $2.7B | $2.4B | $2.0B | $2.1B | $2.5B | $2.1B |
| Current liabilities | $2.0B | $1.4B | $1.5B | $1.7B | $1.4B | $1.3B | $1.6B | $1.4B | $1.7B | $1.3B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $21.1B | $17.4B | $20.4B | $18.8B | $17.7B | $17.1B | $17.5B | $16.9B | $15.8B | $12.6B |
| Total assets | $26.9B | $22.4B | $25.7B | $24.1B | $21.8B | $20.7B | $20.4B | $20.3B | $19.4B | $15.6B |
| Total liabilities | $11.1B | $9.7B | $12.6B | $12.2B | $10.4B | $9.5B | $9.6B | $9.8B | $9.1B | $7.5B |
| Shareholders' equity | $15.8B | $12.7B | $13.1B | $11.9B | $11.4B | $11.2B | $10.8B | $10.4B | $10.3B | $8.1B |
| Margins | ||||||||||
| Gross margin | 54.3% | 53.3% | 40.4% | 30.7% | 36.6% | 33.6% | 34.8% | 29.9% | 37.6% | 39.3% |
| Operating margin | 26.6% | −84.3% | −41.5% | −23.4% | −15.6% | −4.4% | −1.2% | −11.5% | −11.8% | −58.9% |
| EBITDA margin | 48.0% | −56.3% | −14.4% | 4.3% | 9.1% | 24.7% | 27.3% | 14.8% | 9.1% | −42.3% |
| Net margin | 18.7% | −105.2% | −66.1% | −40.6% | −18.0% | −23.2% | −24.1% | −33.7% | −14.5% | −73.5% |
| FCF margin | 15.3% | 22.6% | 12.4% | −1.5% | 4.2% | 14.4% | −10.5% | −9.3% | 5.5% | 15.8% |
| Returns | ||||||||||
| Return on capital | 4.6% | −10.3% | −5.2% | −2.8% | −2.1% | −0.5% | −0.1% | −1.5% | −2.0% | −12.4% |
| Return on capital employed | 4.5% | −10.9% | −5.5% | −3.1% | −2.3% | −0.6% | −0.2% | −1.7% | −2.3% | −14.6% |
| Return on equity | 5.1% | −21.9% | −15.5% | −10.1% | −4.9% | −5.2% | −5.7% | −9.0% | −5.0% | −31.7% |
| Return on assets | 2.9% | −12.7% | −8.3% | −5.0% | −2.5% | −2.8% | −3.0% | −4.7% | −2.6% | −16.7% |
| Growth | ||||||||||
| Revenue growth | −43.7% | −28.6% | 1.5% | 2.3% | 2.1% | −18.9% | 0.7% | 10.0% | 24.4% | 12.5% |
| Net income growth | −10.1% | −501.9% | — | — | — | — | — | — | — | — |
| EPS growth | −11.9% | −484.6% | — | — | — | — | — | — | — | — |
| FCF growth | −56.0% | 5.8% | −44.4% | −112.6% | — | 175.9% | −173.3% | — | — | 224.4% |
| Share count change | 1.1% | 6.5% | 19.7% | 30.8% | 0.5% | 3.6% | 9.7% | 9.9% | 20.4% | 3.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.7x | — | — | 59.3x | 23.1x | 9.8x | 9.5x | 15.9x | 19.6x | — |
| Debt / equity | 0.5x | 0.6x | 0.8x | 0.8x | 0.7x | 0.6x | 0.7x | 0.7x | 0.7x | 0.7x |
| Interest coverage | 2.7x | −5.1x | −2.0x | −1.1x | −0.9x | −0.3x | −0.1x | −0.5x | −1.2x | −4.2x |
| Current ratio | 2.6x | 3.4x | 2.7x | 2.1x | 2.0x | 1.9x | 1.3x | 1.5x | 1.5x | 1.6x |
| Quick ratio | 2.6x | 3.4x | 2.7x | 2.1x | 2.0x | 1.9x | 1.3x | 1.5x | 1.5x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 32.3% | 16.7% | 6.1% | 12.5% | 8.4% | 8.1% | 27.8% | 15.1% | 7.2% | 3.1% |
| Stock comp / revenue | 1.0% | 1.4% | 1.5% | 1.2% | 1.0% | 1.1% | 1.1% | 1.4% | 1.3% | 0.9% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% | — | — | 0.0% | 0.0% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 4.0 | 4.0 | 4.0 | 6.0 | 3.0 | 4.0 | 4.0 | 6.0 | 6.0 |
| Altman Z'' | 3.2 | 1.9 | 1.4 | 1.2 | 1.1 | 1.2 | 0.8 | 0.6 | 0.6 | −1.1 |
| Accruals ratio | −4.5% | −17.4% | −10.6% | −6.4% | −4.2% | −5.5% | −5.2% | −5.5% | −4.8% | −20.9% |
Source: SEC EDGAR XBRL filings (CIK 0001451505). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.